Symbol
DTIL on Nasdaq
Investment type
Equity / Common Shares
Latest Disclosed Ownership
414K shares
Security Ownership
3.7%

Novartis Pharma AG ownership in PRECISION BIOSCIENCES INC Common Shares (DTIL)

2025-08-06 - Novartis Pharma AG has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 414K shares of PRECISION BIOSCIENCES INC Common Shares (DTIL). This represents 3.7% percent ownership of the company.